Monday, March 11, 2024: 1:00pm - 2:30pm ET
HRPPs and Single IRB: A Landscape Analysis
In response to actions by federal agencies that created a single IRB environment (e.g., the National Institutes of Health policy and revisions to the Common Rule), human research protection programs (HRPPs) evolved to meet these new conditions. An expected regulatory change (i.e., updates to US Food and Drug Administration, FDA, regulations) will further drive HRPPs to adapt to single IRB.
Presenters Megan Kasimatis Singleton (Johns Hopkins University School of Medicine) and Joshua Fedewa (University of Michigan) will explore the current single IRB landscape and its effects on organizations, as well as what further evolution we may see if (likely when) the US FDA regulations go into effect. They will discuss what processes and policies organizations have developed that work well for single IRB review in addition to identifying emerging issues and field trends for HRPPs.
At the end of this webinar, attendees will be able to:
- Describe key responsibilities AAHRPP’s Standard I-9 outlines for accredited organizations related to single IRB review
- Recognize critical challenges that single IRB presents for HRPPs and their potential solutions
- Identify opportunities that arise for organizations when adapting to single IRB
|